EDITORIAL
Idiopathic Pulmonary Fibrosis patients’ COVID-19 quarantine; not just a routine
 
More details
Hide details
1
Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, Larissa, Greece
 
 
Corresponding author
Ilias E. Dimeas   

Department of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, BIOPOLIS, 41110, Larissa, Greece
 
 
Pneumon 2020;33(2):1-3
 
KEYWORDS
ABBREVIATIONS
IPF: Idiopathic pulmonary fibrosis, COVID-19: Corona Virus Disease 19, QoL: quality of life
CONFLICTS OF INTEREST
None
AUTHORS' CONTRIBUTIONS
All authors contributed equally in the production of the manuscript.
 
REFERENCES (6)
1.
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708-20. DOI:10.1056/NEJMoa2002032.
 
2.
Barratt S, Creamer A, Hayton C, Chaudhuri N. Idiopathic Pulmonary Fibrosis (IPF): An Overview. J Clin Med 2018; 7:201.
 
3.
Caminati A, Lonati C, Cassandro R, et al. Comorbidities in idiopathic pulmonary fibrosis: An underestimated issue. Eur Respir Rev 2019; 28(153).
 
4.
Van Manen MJG, Geelhoed JJM, Tak NC, Wijsenbeek MS. Optimizing quality of life in patients with idiopathic pulmonary fibrosis. Ther Adv Respir Dis 2017; 11:157–69.
 
5.
Van Manen MJG, Kreuter M, van den Blink B, et al. What patients with pulmonary fibrosis and their partners think: A live, educative survey in the Netherlands and Germany. ERS Monogr 2017; 3(1).
 
6.
Antoniou K, Bolaki M, Bibaki E, et al. COVID19 alert Do we know our enemy?. Pneumon 2020, 33:-25-7.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top